Safe S.A. specializes in the design, manufacture and marketing of medical devices for spine surgery. The company offers implants and instruments in the range of SteriSpine (the first spinal arthrodesis system that is for single use and is sterile and totally traceable). The group's activity is organized around 2 areas: - direct and indirect sales of medical devices (Safe Orthopaedics): business carried out in France, Germany, the United Kingdom, the United States and South America; - subcontracted manufacturing services for orthopedic medical devices (Safe Medical).

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Market Cap	160K 182K 147K 137K 258K 17.29M 263K 1.77M 685K 8.49M 683K 668K 29.53M	P/E 2023 *	-	P/E 2024	-77.6x
Enterprise Value	11.63M 13.25M 10.71M 9.98M 18.81M 1.26B 19.2M 129M 49.89M 618M 49.74M 48.66M 2.15B	EV / Sales 2023	46.6x	EV / Sales 2024	2.39x
Free-Float	95.95%	Yield 2023 *	-	Yield 2024	-

06-30	Safe Group sharply improves its full-year results
06-29	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
05-29	Safe And ABL Alpstein Sign Exclusive Distribution Agreement For SteriSpine Range In Peru	CI
05-29	Safe Group enters Peru with exclusive distribution agreement
03-16	Changes to the SAFE Board of Directors
12-17	Safe Orthopaedics Signs Exclusive Distribution Agreement for Spanish Market	MT
12-17	Safe Group Signs Strategic Distribution Agreement in Spain with Vortrom Biologics	CI
12-01	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2024	CI
28/07/25	Alert wrongly tagged to Safe SA withdrawn	RE
28/12/24	Safe Orthopaedics SA Reports Earnings Results for the Half Year Ended June 30, 2024	CI
09/09/24	The market burns its idols
06/02/24	Safe: wins its appeal against Neo Medical
28/12/23	Safe: audit initiated for a turnaround plan

12-22	SAFE, SPONSOR OF THE 12TH MAMMI INTERNATIONAL CONFERENCE IN ITALY	GL
12-17	SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS	GL
12-17	SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS	AQ
09/09/24	New bond financing agreement in a minimum amount of €3 million in anticipation of validation of the continuation plan	GL
25/11/23	Safe group announces the convocation of the Annual General Meeting of Shareholders to be held on December 15th 2023 and provides an update on the situation	AQ

06-30	Safe Group améliore nettement ses résultats annuels
05-29	Safe Group s'implante au Pérou avec un accord de distribution exclusif
04-29	Safe S A : Report de la publication des résultats annuels 2025 de SAFE Group
03-31	SAFE - Forte dynamique de développement au Venezuela
03-16	Evolutions au sein du Conseil d'Administration de SAFE

Manager	Title	Age	Since
Nicolas Papillon CEO	Chief Executive Officer	46	-
Thomas Droulout CTO	Chief Tech/Sci/R&D Officer	50	15/02/2010
François-Henri Reynaud DFI	Director of Finance/CFO	-	09/11/2017

Safe Orthopaedics Stock Euronext Paris

Stocks

Medical Equipment, Supplies & Distribution

Valuation: Safe Orthopaedics

Latest news : Safe Orthopaedics

Press Releases: Safe Orthopaedics

News in other languages: Safe Orthopaedics

Quotes and Performance

Managers and Directors: Safe Orthopaedics

Medical Devices & Implants

Financials

Company Profile

Director	Title	Age	Since
Thomas Droulout BRD	Director/Board Member	50	-
François-Henri Reynaud BRD	Director/Board Member	-	26/11/2019
Ismaël Nujurally BRD	Director/Board Member	69	26/11/2019

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SAFE ORTHOPAEDICS	-0.79%	-8.36%	-	-	66.7K
STRYKER CORPORATION	-1.29%	-0.90%	-21.65%	+4.31%	121B
SMITH & NEPHEW PLC	+0.37%	-5.03%	-2.19%	-8.41%	12.28B
GLAUKOS CORPORATION	-0.72%	+0.65%	+35.25%	+98.97%	8.2B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+3.39%	-1.02%	-48.42%	-71.63%	3.87B
DOUBLE MEDICAL TECHNOLOGY INC.	+2.37%	+1.71%	+18.02%	+37.61%	2.51B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	+2.95%	+6.84%	-10.54%	-13.42%	1.81B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	+2.50%	+2.32%	+2.76%	-24.74%	1.58B
L&C BIO CO.,LTD	+0.33%	+3.19%	+226.85%	+162.52%	1.57B
Average	+1.04%	+1.62%	+25.01%	+23.15%	19.07B
Weighted average by Cap.	-0.83%	+1.39%	-14.10%	+8.12%

	2023	2024
Net sales	5.81M 6.62M 5.35M 4.98M 9.4M 629M 9.59M 64.32M 24.92M 309M 24.85M 24.31M 1.07B	5.04M 5.74M 4.64M 4.32M 8.15M 546M 8.32M 55.81M 21.62M 268M 21.56M 21.09M 932M
Net income	-205M -234M -189M -176M -332M -22.25B -339M -2.27B -881M -10.92B -879M -860M -38B	-1.93B -2.2B -1.78B -1.65B -3.12B -209B -3.18B -21.36B -8.28B -103B -8.25B -8.07B -357B
Net Debt	270M 308M 249M 232M 437M 29.28B 446M 2.99B 1.16B 14.37B 1.16B 1.13B 50.02B	11.47M 13.06M 10.56M 9.84M 18.56M 1.24B 18.93M 127M 49.2M 610M 49.05M 47.99M 2.12B